Elite Pharmaceuticals Inc (ELTP)
0.1325
0.00 (0.00%)
USD |
OTCM |
Apr 26, 15:59
Elite Pharmaceuticals Shareholders Equity (Quarterly): 46.41M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 46.41M |
September 30, 2023 | 45.09M |
June 30, 2023 | 30.12M |
March 31, 2023 | 28.96M |
December 31, 2022 | 30.17M |
September 30, 2022 | 27.19M |
June 30, 2022 | 25.53M |
March 31, 2022 | 25.22M |
December 31, 2021 | 22.79M |
September 30, 2021 | 20.50M |
June 30, 2021 | 18.70M |
March 31, 2021 | 16.15M |
December 31, 2020 | 16.63M |
September 30, 2020 | 14.62M |
June 30, 2020 | 11.79M |
March 31, 2020 | 10.66M |
December 31, 2019 | 9.080M |
September 30, 2019 | 10.85M |
June 30, 2019 | 12.04M |
March 31, 2019 | -2.508M |
December 31, 2018 | 13.64M |
September 30, 2018 | 15.67M |
June 30, 2018 | 16.99M |
March 31, 2018 | 18.48M |
December 31, 2017 | 19.89M |
Date | Value |
---|---|
September 30, 2017 | 20.09M |
June 30, 2017 | 17.68M |
March 31, 2017 | 25.66M |
December 31, 2016 | 26.05M |
September 30, 2016 | 22.48M |
June 30, 2016 | 15.54M |
March 31, 2016 | 11.16M |
December 31, 2015 | -2.069M |
September 30, 2015 | 12.49M |
June 30, 2015 | -15.32M |
March 31, 2015 | 0.2689M |
December 31, 2014 | -30.54M |
September 30, 2014 | -55.36M |
June 30, 2014 | -84.45M |
March 31, 2014 | -81.20M |
December 31, 2013 | -4.927M |
September 30, 2013 | -5.852M |
June 30, 2013 | -6.400M |
March 31, 2013 | -8.673M |
December 31, 2012 | -12.36M |
September 30, 2012 | -21.80M |
June 30, 2012 | -23.36M |
March 31, 2012 | -14.98M |
December 31, 2011 | -14.31M |
September 30, 2011 | -23.69M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
9.080M
Minimum
Dec 2019
46.41M
Maximum
Dec 2023
22.24M
Average
20.50M
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 3.314M |
Palatin Technologies Inc | -11.38M |
iBio Inc | 9.197M |
Theriva Biologics Inc | 39.70M |
Oragenics Inc | 3.168M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 74.70M |
Total Liabilities (Quarterly) | 28.28M |
Debt to Equity Ratio | 0.1642 |
Current Ratio | 1.939 |
Net Debt Paydown Yield | 1.18% |